Under the agreement, Myung In Pharma is set to contribute 10% of the subjects to be enrolled for Newron's upcoming trial.

Have an issue with your financial planner or looking for a new one? Email questions or concerns to picks@marketwatch.com.

Despite a cautious deal market and continuing economic and political uncertainty as 2024 began, Dechert remained active in the financial services ...

Leading M&A partners are predicting an increase in deal activity in 2025 driven by sectors including tech, financial services ...

Houston's largest private company will be acquired by a publicly traded utilities company based in Baltimore in a deal worth ...

Tarique Siddique was Sheikh Hasina's defence adviser while his wife Shaheen Siddique is the aunt of Tulip Siddiq ...

Shackleton, the advice business led by former Quilter chief executive Paul Feeney, charges clients from £400 a year to ...

Defaqto, one of the UK’s most trusted sources of financial product and market intelligence, has identified the top 10 most ...

The Financial Services Compensation Scheme has declared Glasgow-based firm Broadfoot, McKee and Hamilton in default.

If you're wondering what moves to make with a new president moving into the White House, you're being dangerously ...

Chicago still has time to voluntarily address its financial issues before ultimately defaulting on its debt, which led to Detroit filing for bankruptcy in 2013.

Retirees face unique challenges, such as managing fixed incomes, navigating healthcare costs, and ensuring their savings last ...